Fitbit has completed clinical trials of its own ECG feature and is looking to get FDA approval – as it launches a large scale study into Afib and irregular heart rate detection. The mass Fitbit Heart ...

Even minor ECG abnormalities detected with annual checks signal a greater risk of future CVD events, a study of several million working-age people affirms, although questions remain about whether ...

HeartBeam’s synthesised 12-lead electrocardiogram (ECG) has met the clinical endpoints in the VALID-ECG pivotal study, assessing non-life-threatening arrhythmias. In the study, the mean difference in ...

Please provide your email address to receive an email when new articles are posted on . Abnormal ECG findings were rare in elite female basketball players. These data may serve as a reference for ...

From the Oura Ring to the Apple Watch to the Google Pixel — here's what the science really says about the accuracy of their health data ...

NEW YORK, February 10, 2026--(BUSINESS WIRE)--AccurKardia, an innovator in ECG-based diagnostics technology, today announced results from a new study demonstrating that its AI-enabled ECG technology, ...

HeartBeam’s technology uniquely capable of assessing possible heart attacks outside of traditional clinical settings ALIGN-ACS study expected to complete patient enrollment quickly Milestone signifies ...

(RTTNews) - HeartBeam, Inc., (BEAT), a medical technology company, Tuesday said its synthesized 12-lead electrocardiogram (ECG) met the clinical endpoints in the VALID-ECG pivotal study. The study ...

Can atrial fibrillation and atrial flutter be accurately detected using a smartphone-operated single-lead electrocardiography device? A smartphone-operated, single-lead electrocardiography (1L-ECG) ...

GUILDFORD, UK — Obtaining an ECG in the prehospital setting makes it more likely patients with ST-elevation MI (STEMI) will get reperfusion therapy and, in both STEMI and non-ST-elevation MI (NSTEMI) ...